HomeArticlesToday's HighlightsArqule's Targeting c-Met for Liver Cancer, Human Genomes Poison Pill and Other Important News
Today's Highlights
Premium

Arqule's Targeting c-Met for Liver Cancer, Human Genomes Poison Pill and Other Important News

The market opened down today. Our cancer stocks, IMGN, SGEN are up, while INCY, and ARIA, seem to be losing a little to profit-takings. ONXX and PCYC are rallying. DNDN is the largest loser. We will t...
P

Prohost Biotech

1 min read
3
0

Unlock Premium Content

This article contains exclusive content for our premium subscribers. Join our community to access in-depth research, expert insights, and comprehensive analysis.

Unlimited articles
Expert analysis
Research reports

Comments (0)

Please sign in to join the discussion